UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 27,
GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more GT Biopharma Charts.
GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more GT Biopharma Charts.

Gt Biopharma, Inc. News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 21 December 2023 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 4 December 2023 (5 months ago) • Edgar (US Regulatory)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 1 November 2023 (6 months ago) • Edgar (US Regulatory)
Form PRE 14A - Other preliminary proxy statements
Friday 27 October 2023 (6 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Tuesday 19 September 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 22 August 2023 (8 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 15 August 2023 (9 months ago) • Edgar (US Regulatory)

More Gt Biopharma, Inc. News Articles